RxDoctor Payments DataLook up a doctor →

Phillip Toth

Internal Medicine · Indianapolis, INNPI 1891098034

Payments from drug & device makers

$3,215,099in general payments, 2019–2025

Across 1,272 payments — averaging $2527.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1.5M
  • AstraZeneca$784K
  • Eli Lilly$516K
  • Pfizer$218K
  • Novartis$186K
  • Akcea Therapeutics, Inc.$27K
  • plus $16K from 6 others
$4,557in research payments, 2019–2025

Across 9 payments — averaging $506.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

What the payments were for

  • Travel & lodging$39959%
  • Food & beverage$20831%
  • Education$6510%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,215,099 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Other internal medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →